BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Violi F, Corazza GR, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S; PRO-LIVER Collaborators. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. Intern Emerg Med. 2016;11:1059-1066. [PMID: 27026379 DOI: 10.1007/s11739-016-1416-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Violi F, Loffredo L, Pastori D. Anticoagulation in patients with advanced liver disease: an open issue. Intern Emerg Med 2021;16:61-71. [PMID: 33073317 DOI: 10.1007/s11739-020-02526-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Eshraghian A, Nikeghbalian S, Kazemi K, Mansoorian M, Shamsaeefar A, Eghlimi H, Gholami S, Salahi H, Malek‐hosseini SA. Portal vein thrombosis in patients with liver cirrhosis and its impact on early and long‐term outcomes after liver transplantation. Int J Clin Pract 2018;73:e13309. [DOI: 10.1111/ijcp.13309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Violi F, Pastori D, Farcomeni A, Loffredo L. Reply. Gastroenterology 2018;154:761-762.e1. [PMID: 29351834 DOI: 10.1053/j.gastro.2018.01.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Basili S, Pastori D, Raparelli V, Violi F. Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician. Therap Adv Gastroenterol 2018;11:1756284818793561. [PMID: 30202445 DOI: 10.1177/1756284818793561] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zampino R, Lebano R, Coppola N, Macera M, Grandone A, Rinaldi L, De Sio I, Tufano A, Stornaiuolo G, Adinolfi LE, Durante-Mangoni E, Battista GG, Niglio A. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol 2018;24:25-9. [PMID: 29451181 DOI: 10.4103/sjg.SJG_100_17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, Turco L, Dragoni G, Laffi G, Marra F. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med 2020;15:37-48. [DOI: 10.1007/s11739-019-02252-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
7 Sharma AK, Kaufman DC. TIPS performed in a patient with complete portal vein thrombosis. Radiol Case Rep 2017;12:327-30. [PMID: 28491181 DOI: 10.1016/j.radcr.2017.01.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Stine JG, Northup PG. Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis. Dig Dis Sci 2019;64:619-26. [PMID: 30560339 DOI: 10.1007/s10620-018-5427-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
9 Jiang TT, Luo XP, Sun JM, Gao J. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World J Gastroenterol 2017; 23(41): 7470-7477 [PMID: 29151701 DOI: 10.3748/wjg.v23.i41.7470] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
10 Bartell N, Al-Judaibi B. The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon. Saudi J Gastroenterol 2018;24:3-4. [PMID: 29451177 DOI: 10.4103/sjg.SJG_588_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bos I, Blondeau M, Wouters D, Camus C, Houssel-Debry P, van der Plas WS, Nieuwenhuis LM, Bardou-Jacquet E, Lisman T, de Meijer VE, Porte RJ, Rayar M. Therapeutic anticoagulation after liver transplantation is not useful among patients with pre-transplant Yerdel-grade I/II portal vein thrombosis: A two-center retrospective study. J Thromb Haemost 2021. [PMID: 34297481 DOI: 10.1111/jth.15472] [Reference Citation Analysis]
12 Talon L, Sinegre T, Lecompte T, Pereira B, Massoulié S, Abergel A, Lebreton A. Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST‐Genesia. J Thromb Haemost 2020;18:2177-90. [DOI: 10.1111/jth.14963] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
13 Riva N, Ageno W. Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's Perspective. J Transl Int Med 2018;6:6-10. [PMID: 29607297 DOI: 10.2478/jtim-2018-0002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Ronca V, Podda GM, Cattaneo M. An "unmodifiable" risk factor that has been modified. Intern Emerg Med 2021;16:157-9. [PMID: 31396923 DOI: 10.1007/s11739-019-02170-9] [Reference Citation Analysis]
15 Hernández-Conde M, Llop E, Fernández-Carrillo C, Perelló C, López-Gómez M, Abad J, Martínez-Porras JL, Fernández-Puga N, Calleja JL. Visceral fat is associated with cirrhotic portal vein thrombosis. Expert Rev Gastroenterol Hepatol 2019;13:1017-22. [PMID: 31393183 DOI: 10.1080/17474124.2019.1651644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol 2018;31:315-29. [PMID: 29720857 DOI: 10.20524/aog.2018.0245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Ambrosino P, Tarantino L, Di Minno G, Paternoster M, Graziano V, Petitto M, Nasto A, Di Minno MN. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thromb Haemost. 2017;117:139-148. [PMID: 27761574 DOI: 10.1160/th16-06-0450] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
18 Basili S, Carnevale R, Nocella C, Bartimoccia S, Raparelli V, Talerico G, Stefanini L, Romiti GF, Perticone F, Corazza GR, Piscaglia F, Pietrangelo A, Violi F; PRO‐LIVER Collaborators. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis. Hepatol Commun 2019;3:504-12. [PMID: 30976741 DOI: 10.1002/hep4.1317] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
19 Noronha Ferreira C, Marinho RT, Cortez-Pinto H, Ferreira P, Dias MS, Vasconcelos M, Alexandrino P, Serejo F, Pedro AJ, Gonçalves A, Palma S, Leite I, Reis D, Damião F, Valente A, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study. Liver Int 2019;39:1459-67. [PMID: 31021512 DOI: 10.1111/liv.14121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
20 Gîrleanu I, Trifan A, Stanciu C, Sfarti C. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture. World J Gastroenterol 2018; 24(39): 4419-4427 [PMID: 30356984 DOI: 10.3748/wjg.v24.i39.4419] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
21 Wu WY, Kong DR. Advances in diagnosis and treatment of portal venous thrombosis. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 165-173 [DOI: 10.11569/wcjd.v29.i4.165] [Reference Citation Analysis]
22 Dai CY, Chuang WL, Yu ML. Predicting portal thrombosis in cirrhosis: Some issues. J Hepatol 2021:S0168-8278(21)02010-9. [PMID: 34461209 DOI: 10.1016/j.jhep.2021.08.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tufano A, Ageno W, Di Micco P, Niglio A, Rosa V, Ballaz A, Braester A, Rubio CM, Isern V, Imbalzano E, Monreal M. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. Thrombosis Research 2018;164:69-74. [DOI: 10.1016/j.thromres.2018.02.143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
24 Mannucci PM, Tripodi A. Direct oral anticoagulants and cirrhosis: More evidence still needed for efficacy and safety in portal vein thrombosis. Vascul Pharmacol 2019;113:92-3. [PMID: 29890295 DOI: 10.1016/j.vph.2018.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
25 Northup P, Davis J. Shortcomings in Design and Analysis of Clinical Studies on Bleeding and Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost 2020;46:665-72. [PMID: 32757183 DOI: 10.1055/s-0040-1714203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Liew A, Douketis J. Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? Intern Emerg Med 2016;11:1037-40. [PMID: 27216797 DOI: 10.1007/s11739-016-1463-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F; PRO-LIVER Collaborators. Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study. Am J Gastroenterol 2018;113:368-75. [PMID: 29257146 DOI: 10.1038/ajg.2017.457] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
28 Lopez-Gomez M, Llop E, Puente A, Hernández Conde M, Ruiz P, Alvárez S, Martínez JL, Abad J, Fernández N, Perelló C, Fernández-Carrillo C, Ferre C, Trapero M, Fraga E, Crespo J, Calleja Panero JL. Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors. Hepatol Res 2021. [PMID: 34324766 DOI: 10.1111/hepr.13703] [Reference Citation Analysis]
29 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 28.0] [Reference Citation Analysis]
30 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
31 Riva N, Ageno W. Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses. Thromb Res 2018;163:252-9. [PMID: 28673473 DOI: 10.1016/j.thromres.2017.06.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Pettinari I, Vukotic R, Stefanescu H, Pecorelli A, Morelli M, Grigoras C, Sparchez Z, Andreone P, Piscaglia F; BO-LIVES (BOlogna LIVEr vascular Studies). Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis. Am J Gastroenterol. 2019;114:258-266. [PMID: 30538290 DOI: 10.1038/s41395-018-0421-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 14.7] [Reference Citation Analysis]
33 Xu X, Guo X, De Stefano V, Silva-Junior G, Goyal H, Bai Z, Zhao Q, Qi X. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Hepatol Int 2019;13:468-81. [PMID: 31175581 DOI: 10.1007/s12072-019-09951-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
34 Riva N, Attard LM, Vella K, Squizzato A, Gatt A, Calleja-Agius J. Diagnostic accuracy of D-dimer in patients at high-risk for splanchnic vein thrombosis: A systematic review and meta-analysis. Thromb Res 2021;207:102-12. [PMID: 34600286 DOI: 10.1016/j.thromres.2021.09.016] [Reference Citation Analysis]
35 Nacif LS, Zanini LY, Pinheiro RS, Waisberg DR, Rocha-Santos V, Andraus W, Carrilho FJ, Carneiro-D'Albuquerque L. Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis. Clinics (Sao Paulo) 2021;76:e2184. [PMID: 33503185 DOI: 10.6061/clinics/2021/e2184] [Reference Citation Analysis]
36 Costache RS, Dragomirică AS, Dumitraș EA, Mariana J, Căruntu A, Popescu A, Costache DO. Portal vein thrombosis: A concise review (Review). Exp Ther Med 2021;22:759. [PMID: 34035856 DOI: 10.3892/etm.2021.10191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Xu X, Xu S, Primignani M, De Stefano V, He Y, Yi F, Guo X, Valla D, Qi X. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study. Adv Ther 2020;37:1452-63. [PMID: 32076942 DOI: 10.1007/s12325-020-01250-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
38 Riva N, Ageno W. Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions. J Clin Med 2020;9:E743. [PMID: 32164214 DOI: 10.3390/jcm9030743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
39 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 26.3] [Reference Citation Analysis]
40 Praktiknjo M, Trebicka J, Carnevale R, Pastori D, Queck A, Ettorre E, Violi F. Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis. Clin Transl Gastroenterol 2020;11:e00123. [PMID: 32032127 DOI: 10.14309/ctg.0000000000000123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
41 Cui S, Fu Z, Feng Y, Xie X, Ma X, Liu T, Wang L, Wu H, Zhu Q. The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B. Thromb Res 2018;161:7-11. [PMID: 29178991 DOI: 10.1016/j.thromres.2017.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
42 Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond) 2017;17:212-9. [PMID: 28572222 DOI: 10.7861/clinmedicine.17-3-212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
43 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol 2019; 25(31): 4437-4451 [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
44 Gaballa D, Bezinover D, Kadry Z, Eyster E, Wang M, Northup PG, Stine JG. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index. Liver Transpl 2019;25:1747-55. [PMID: 31436367 DOI: 10.1002/lt.25630] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
45 Zhang R, Huang X, Jiang Y, Wang J, Chen S. Effects of Anticoagulants on Experimental Models of Established Chronic Liver Diseases: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol 2020;2020:8887574. [PMID: 33381477 DOI: 10.1155/2020/8887574] [Reference Citation Analysis]
46 Makoto I, Usui M, Wada H, Matsumoto T, Ohishi K, Shindo A, Yamashita Y, Nakatani K, Tamaki S, Tomimoto H, Isaji S. Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis. Clin Appl Thromb Hemost 2018;24:1117-21. [PMID: 29747524 DOI: 10.1177/1076029618774146] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]